An agent selected from: (a) interferon-ß (IFN-ß); (b) an agent that increases IFN-ß expression; or (c) a polynucleotide which is capable of expressing (a) or (b); for use in the treatment of individuals with lower respiratory tract illness that has developed during or following an established ILI, wherein said treatment is by airway delivery of said medicament.
申请公布号
WO2011110861(A2)
申请公布日期
2011.09.15
申请号
WO2011GB50480
申请日期
2011.03.10
申请人
SYNAIRGEN RESEARCH LIMITED;TEAR, VICTORIA JANE;ROBERTS, JAMES JONATHAN WELCH;MONK, PHILLIP DAVID
发明人
TEAR, VICTORIA JANE;ROBERTS, JAMES JONATHAN WELCH;MONK, PHILLIP DAVID